Novel phosphorylation sites of human tumour suppressor protein p53 at Ser20 and Thr18 that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancers.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Biochemical Journal

• Publication date

  1999-08-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1042/0264-6021:3420133PMID 10432310PMCID PMC1220446
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of the oligomerization defects of two p53 mutants found in families with Li–Fraumeni and Li–Fraumeni-like syndrome

  1998cited by this paper
• Activation of the ATM kinase by ionizing radiation and phosphorylation of p53.

  1998cited by this paper
• DNA damage triggers DRB-resistant phosphorylation of human p53 at the CK2 site

  1998cited by this paper
• p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities.

  1998cited by this paper
• Deletion of the Saccharomyces cerevisiae TRR1 Gene Encoding Thioredoxin Reductase Inhibits p53-dependent Reporter Gene Expression*

  1998cited by this paper
• Phosphorylation of p53: a Novel Pathway for p53 Inactivation in Human T-Cell Lymphotropic Virus Type 1-Transformed Cells

  1998cited by this paper
• ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins

  1998cited by this paper
• p53 is a general repressor of RNA polymerase III transcription

  1998cited by this paper
• The promise of molecular oncology.

  1998cited by this paper
• Enhanced phosphorylation of p53 by ATM in response to DNA damage.

  1998cited by this paper
• Characterization of p53 oligomerization domain mutations isolated from Li–Fraumeni and Li–Fraumeni like family members

  1998cited by this paper
• Phosphorylation of p53 Serine 15 Increases Interaction with CBP*

  1998cited by this paper
• Biochemical analysis of the stress protein response in human oesophageal epithelium

  1997cited by this paper
• Restoration of the growth suppression function of mutant p53 by a synthetic peptide derived from the p53 C-terminal domain

  1997cited by this paper
• Reciprocal interference between the sequence-specific core and nonspecific C-terminal DNA binding domains of p53: implications for regulation

  1997cited by this paper
• Lonely no more: p53 finds its kin in a tumor suppressor haven.

  1997cited by this paper
• High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers.

  1997cited by this paper
• Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers.

  1997cited by this paper
• Molecular characterization of the hdm2-p53 interaction.

  1997cited by this paper
• DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2.

  1997cited by this paper
• Protein interactions at the carboxyl terminus of p53 result in the induction of its in vitro transactivation potential

  1997cited by this paper
• A mutation in a thioredoxin reductase homolog suppresses p53-induced growth inhibition in the fission yeastSchizosaccharomyces pombe

  1996cited by this paper
• Structural aspects of the p53 protein in relation to gene evolution: a second look.

  1996cited by this paper
• Tumor suppressor p53 gene forms multiple isoforms: evidence for single locus origin and cytoplasmic complex formation with heat shock proteins.

  1996cited by this paper
• Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain

  1996cited by this paper
• p53 inhibits RNA polymerase III-directed transcription in a promoter-dependent manner

  1996cited by this paper
• Human p53 expressed in baculovirus-infected Sf9 cells displays a two-dimensional isoform pattern identical to wild-type p53 from human cells.

  1996cited by this paper
• Thermodynamic analysis of the structural stability of the tetrameric oligomerization domain of p53 tumor suppressor.

  1995cited by this paper
• Transforming growth factor β1 is unlikely to mediate p53 abnormalities in breast cancer

  1995cited by this paper
• Small peptides activate the latent sequence-specific DNA binding function of p53.

  1995cited by this paper
• Characterisation of epitopes on human p53 using phage-displayed peptide libraries: insights into antibody-peptide interactions.

  1995cited by this paper
• Two Distinct Signaling Pathways Activate the Latent DNA Binding Function of p53 in a Casein Kinase II-independent Manner (*)

  1995cited by this paper
• Conformational changes in p53 analysed using new antibodies to the core DNA binding domain of the protein.

  1995cited by this paper
• PAK1, a gene that can regulate p53 activity in yeast.

  1995cited by this paper
• Regulation of the Sequence-specific DNA Binding Function of p53 by Protein Kinase C and Protein Phosphatases (*)

  1995cited by this paper
• Altered protein synthesis in p53 null and hemizygous transgenic mouse embryonic fibroblasts.

  1995cited by this paper
• Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms

  1995cited by this paper
• Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein.

  1994cited by this paper
• Allosteric activation of latent p53 tetramers.

  1994cited by this paper
• Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.

  1994cited by this paper
• Sequence-specific transcriptional activation is essential for growth suppression by p53.

  1994cited by this paper
• In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice.

  1993cited by this paper
• On target with a new mechanism for the regulation of protein phosphorylation.

  1993cited by this paper
• Activation of the cryptic DNA binding function of mutant forms of p53.

  1993cited by this paper
• A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein.

  1993cited by this paper
• Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53

  1992cited by this paper
• Human p53 inhibits growth in Schizosaccharomyces pombe

  1992cited by this paper
• Mammalian p53 can function as a transcription factor in yeast.

  1992cited by this paper
• Refinement of the Coomassie brilliant blue G assay for quantitative protein determination.

  1989cited by this paper

• Mechanistic Role of the Mdm2/MdmX Lid Domain in Regulating Their Interactions with p53

  2025cites this paper
• Spliceosomal Sm core assembly: AlphaFold 3 predicted structure and phosphorylation-dependent regulation of the human 6S complex

  2025cites this paper
• SUMO1-regulated DBC1 promotes p53-dependent stress-induced apoptosis of lens epithelial cells

  2023cites this paper
• hCINAP alleviates senescence by regulating MDM2 via p14ARF and the HDAC1/CoREST complex

  2023cites this paper
• Protein of a thousand faces: The tumor-suppressive and oncogenic responses of p53

  2022cites this paper
• Cancer-Associated Mutations Perturb the Disordered Ensemble and Interactions of the Intrinsically Disordered p53 Transactivation Domain.

  2021cites this paper
• Cancer-Associated Mutations Perturb the Structure and Interactions of the Intrinsically Disordered p53 Transactivation Domain

  2020influential citation
• Autophagy promotes mammalian survival by suppressing oxidative stress and p53

  2020cites this paper
• Tumorigenic and Immunogenic Properties of Induced Pluripotent Stem Cells: a Promising Cancer Vaccine

  2020cites this paper
• CacyBP/SIP protein reduces p53 stability by enhancing Mdm2 activity in p53 mutant glioma cells.

  2020cites this paper
• 6,8‐Diprenylorobol induces apoptosis in human colon cancer cells via activation of intracellular reactive oxygen species and p53

  2020cites this paper
• Harnessing the vulnerabilities of p53 mutants in lung cancer – Focusing on the proteasome: a new trick for an old foe?

  2020cites this paper
• Wild-Type p53 Promotes Cancer Metabolic Switch by Inducing PUMA-Dependent Suppression of Oxidative Phosphorylation.

  2019cites this paper
• Functions of p53 in pluripotent stem cells

  2019cites this paper
• Relevance of the p53–MDM2 axis to aging

  2017cites this paper
• G-actin guides p 53 nuclear transport : potential contribution of monomeric actin in altered localization of mutant p 53

  2017cites this paper
• Cooperating Oncogenic Alterations in Aggressive Pten-Deficient Breast Cancer

  2017cites this paper
• Protein phosphatase Mg2+/Mn2+ dependent 1F promotes smoking-induced breast cancer by inactivating phosphorylated-p53-induced signals

  2016cites this paper
• CIRCUMVENTING CISPLATIN RESISTANCE IN OVARIAN CANCERS THROUGH REACTIVATION OF p53 BY NON-CROSS-RESISTANT PLATINUM ANALOGS

  2016cites this paper
• Drug-dependent functionalization of wild-type and mutant p53 in cisplatin-resistant human ovarian tum3or cells

  2016influential citation
• Selective dysfunction of p53 for mitochondrial biogenesis induces cellular proliferation in bronchial smooth muscle from asthmatic patients.

  2016cites this paper
• A spatiotemporal characterization of the effect of p53 phosphorylation on its interaction with MDM2

  2015cites this paper
• Hepatocellular carcinoma: Putative interactive mechanism between aflatoxins and hepatitis viral infections implicating oxidative stress during the onset and progression of cancer

  2015cites this paper
• Structural and sequential context of p53: A review of experimental and theoretical evidence.

  2015cites this paper
• Regulation of the p53 response and its relationship to cancer.

  2015cites this paper
• Inhibition of p 53-dependent transcription by BOX-I phospho-peptide mimetics that bind to p 300

  2013cites this paper
• Identification and characterization of senescence-associated microRNAs in a mouse model of the XFE progeroid syndrome

  2013cites this paper
• Switching on p53: an essential role for protein phosphorylation?

  2013cites this paper
• Cytoplasmic Translocation of p 53 by Human Cytomegalovirus Infection

  2013cites this paper
• Cytoplasmic Translocation of p53 by Human Cytomegalovirus Infection

  2013cites this paper
• Polymorphisms in G-quadruplex regions of the TP53 tumour suppressor gene : Impact on cancer susceptibility and expression of p53 N-terminal isoforms

  2013cites this paper
• The interaction of p 53 and MDM 2 genes in cancers , in silico studies and phylogenetic

  2012cites this paper
• Resistance and gain-of-resistance phenotypes in cancers harboring wild-type p53.

  2012cites this paper
• Simulating Molecular Mechanisms of the MDM2-Mediated Regulatory Interactions: A Conformational Selection Model of the MDM2 Lid Dynamics

  2012cites this paper
• Atomistic Insights Into the Regulatory Mechanisms Mediated by Post- Translational Modifications: Molecular Dynamics Investigations

  2012cites this paper
• Centriolar and ciliary responses to DNA damage

  2012cites this paper
• The role of microRNAs in the p53 tumor suppressor pathway

  2011cites this paper
• The interaction of p53 and MDM2 genes in cancers, in silico studies and phylogenetic analysis

  2011cites this paper
• The role of ATR mediated p 53 phosphorylatio n at Serine 15 in Homologous

  2011cites this paper
• A Novel p53 Phosphorylation Site within the MDM2 Ubiquitination Signal

  2010cites this paper
• The Regulation of p53 Protein Function by Phosphorylation

  2010cites this paper
• MDM2 inhibitors for pancreatic cancer therapy.

  2010cites this paper
• Puma is required for p53-induced depletion of adult stem cells

  2010cites this paper
• A Novel p53 Phosphorylation Site within the MDM2 Ubiquitination Signal

  2010cites this paper
• A divergent substrate-binding loop within the pro-oncogenic protein anterior gradient-2 forms a docking site for Reptin.

  2010cites this paper
• Tumour suppression by p53: a role for the DNA damage response?

  2009cites this paper
• Study of MDM2 Binding to p53-Analogues: Affinity, Helicity, and Applicability to Drug Design

  2009cites this paper
• p53 polymorphisms: cancer implications

  2009cites this paper
• Two distinct motifs within the p53 transactivation domain bind to the Taz2 domain of p300 and are differentially affected by phosphorylation.

  2009influential citation
• Ascochlorin activates p53 in a manner distinct from DNA damaging agents

  2009cites this paper
• p53 isoforms - A conspiracy to kidnap p53 tumor suppressor activity?

  2009cites this paper
• Structural basis for p300 Taz2-p53 TAD1 binding and modulation by phosphorylation.

  2009cites this paper
• HPV-16E6 can induce multiple site phosphorylation of p53.

  2009cites this paper
• Hyperactive p53 leads to age-related phenotypes in mice model

  2009cites this paper
• p53 ubiquitination by Mdm2: a never ending tail?

  2009cites this paper
• Stochastic Modeling and Simulation of the p53-MDM2/MDMX Loop

  2009cites this paper
• Novel concepts in MDM2 protein regulation

  2009cites this paper
• Serine 15 phosphorylation of p53 directs its interaction with B56gamma and the tumor suppressor activity of B56gamma-specific protein phosphatase 2A.

  2008cites this paper
• The multiple checkpoint functions of CHK1 and CHK2 in maintenance of genome stability.

  2008influential citation
• Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regulate mir-34a, mir-34b, and mir-34c expression, and induce senescence.

  2008cites this paper
• DAPK-1 Binding to a Linear Peptide Motif in MAP1B Stimulates Autophagy and Membrane Blebbing*

  2008cites this paper
• In GFP with high risk HPV-18E6 fusion protein expressed 293T and MCF-7 cells, the endogenous wild-type p53 could be transiently phosphorylated at multiple sites

  2008cites this paper
• PML enhances the regulation of p53 by CK1 in response to DNA damage

  2008cites this paper
• Mdm2 Is Required for Inhibition of Cdk2 Activity by p21, Thereby Contributing to p53-Dependent Cell Cycle Arrest

  2007cites this paper
• Aging-associated truncated form of p53 interacts with wild-type p53 and alters p53 stability, localization, and activity.

  2007cites this paper
• Ubiquitination and Degradation of the Anti-apoptotic Protein ARC by MDM2*

  2007cites this paper
• p53 stabilization can be uncoupled from its role in transcriptional activation by loss of PTTG1/securin.

  2007cites this paper
• Gatekeepers of the Guardian: p53 Regulation by Post-Translational Modification, MDM2 and MDMX

  2007cites this paper
• The MDM2 Ubiquitination Signal in the DNA-Binding Domain of p53 Forms a Docking Site for Calcium Calmodulin Kinase Superfamily Members

  2007cites this paper
• Serine 15 Phosphorylation of p53 Directs Its Interaction with B56γ and the Tumor Suppressor Activity of B56γ-Specific Protein Phosphatase 2A

  2007cites this paper
• p63: The Phantom of the Tumor Suppressor

  2007cites this paper
• Crippling p53 activities via knock-in mutations in mouse models

  2007cites this paper
• Modulation of the p53-MDM2 Interaction by Phosphorylation of Thr18: A Computational Study

  2007influential citation
• Mdm2 Plays a Positive Role as an Effector of p53-Dependent Responses

  2007cites this paper
• Infrared radiation induces the p53 signaling pathway: role in infrared prevention of ultraviolet B toxicity

  2006cites this paper
• Regulating the p53 pathway: in vitro hypotheses, in vivo veritas

  2006cites this paper
• Inhibition of the ATM/p53 Signal Transduction Pathway by Kaposi's Sarcoma-Associated Herpesvirus Interferon Regulatory Factor 1

  2006cites this paper
• Structural studies of kinases involved in the cell cycle control and the structural basis of regulation of insulin-like growth factor binding proteins (IGFBPs)

  2006cites this paper
• INTEGRACIÓN DE LA FUNCIÓN DE VRK2 EN LAS RUTAS DE SEÑALIZACIÓN DE JNK Y P53.

  2006cites this paper
• Tumor susceptibility and apoptosis defect in a mouse strain expressing a human p53 transgene.

  2006cites this paper
• 2 The Three-Dimensional Structure of p 53

  2006cites this paper
• On the mechanism of sequence-specific DNA-dependent acetylation of p53: the acetylation motif is exposed upon DNA binding.

  2006cites this paper
• Differential effects of 5‐aminolaevulinic acid photodynamic therapy and psoralen + ultraviolet A therapy on p53 phosphorylation in normal human skin in vivo

  2005cites this paper
• Extra Views A New Twist in the Feedback Loop Stress-Activated MDM 2 Destabilization is Required for p 53 Activation

  2005cites this paper
• A New Twist in the Feedback Loop: Stress-Activated MDM2 Destabilization is Required for p53 Activation

  2005cites this paper
• The Three-Dimensional Structure of p53

  2005cites this paper
• MDM2 is a central node in the p53 pathway: 12 years and counting.

  2005cites this paper
• Mechanism of cell cycle regulation by FIP200 in human breast cancer cells.

  2005cites this paper
• Differential regulation of signal transduction pathways in wild type and mutated p53 breast cancer epithelial cells by copper and zinc.

  2004cites this paper
• Deacetylation of p53 after nerve growth factor treatment in PC12 cells as a post-translational modification mechanism of neurotrophin-induced tumor suppressor activation

  2004cites this paper
• Structured DNA promotes phosphorylation of p53 by DNA-dependent protein kinase at serine 9 and threonine 18.

  2004cites this paper
• p53 Stabilization and Accumulation Induced by Human Vaccinia-Related Kinase 1

  2004cites this paper
• COP1, the Negative Regulator of p53, Is Overexpressed in Breast and Ovarian Adenocarcinomas

  2004cites this paper
• p53: Twenty five years understanding the mechanism of genome protection

  2004cites this paper
• Effect of pH on radiation-induced p53 expression.

  2004cites this paper
• Interferon Regulatory Factor 1 Binding to p300 Stimulates DNA-Dependent Acetylation of p53

  2004cites this paper
• Advances in Brief COP 1 , the Negative Regulator of p 53 , Is Overexpressed in Breast and Ovarian Adenocarcinomas

  2004cites this paper
• Expansion of protein interaction maps by phage peptide display using MDM2 as a prototypical conformationally flexible target protein.

  2004cites this paper
• Aurora-A Abrogation of p53 DNA Binding and Transactivation Activity by Phosphorylation of Serine 215*

  2004cites this paper
• Accelerated MDM2 auto‐degradation induced by DNA‐damage kinases is required for p53 activation

  2004cites this paper